Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6MHP Vaccine and Keytruda in Advanced Melanoma
NCT02515227Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Mar 2020
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of melanoma helper peptide vaccine in melanoma. Started Oct 2016; status: completed.
02
Drugs
melanoma helper peptide vaccine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02515227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515227.